General MedicationsORALGeneric
LEVONORGESTREL
LEVONORGESTREL
Standard Dose
0.75MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview LEVONORGESTREL is listed in Drugs@FDA under application 202740 (ANDA).
Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength TABLET;ORAL - 0.75MG Sponsor XIROMED Submission history Latest submission status date: 2016-09-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVONORGESTREL is listed in Drugs@FDA under application 202740 (ANDA). Marketing status: Discontinued Active ingredient LEVONORGESTREL Form and strength TABLET;ORAL - 0.75MG Sponsor XIROMED Submission history Latest submission status date: 2016-09-02 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.